Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

The concept of mixed connective tissue disease (MCTD) as a separate connective tissue
disease (CTD) has persisted for more than four decades. High titers of antibodies targeting …

Objectives To assess the prevalence, extent, progression, functional impact and mortality of
interstitial lung disease (ILD) in a nationwide unselected MCTD cohort. Methods The study …

Abstract Mixed Connective Tissue Disease (MCTD) is an autoimmune disease first
described by Sharp et al in 1972, characterized by the presence of anti-Ribonucleoprotein …

Abstract Introduction Connective Tissue Diseases (CTDs) are systemic autoimmune
conditions characterized by frequent lung involvement. This usually takes the form of …

OBJECTIVES Interstitial lung disease (ILD) is a key prognostic factor in connective tissue
disorders (CTDs). The aim of our study was to assess the changes in pulmonary functional …

High-resolution computed tomography (HRCT) of the lung is a key component of the
multidisciplinary approach to diagnosis in diffuse lung disease (DLD). HRCT also plays an …

Objective We aimed to compare two matched populations of patients with MTCD with and
without associated ILD and to identify predictive factors for ILD progression and severity …

An understanding of the characteristics of ILD in SjS, MCTD, and SLE is important for the
pulmonary specialist. Future research should identify risk factors for progression and …

Highlights The working group of the Polish Respiratory Society (PTChP) developed
guidelines for diagnosis and treatment of PF-ILD. What are the main findings? A …